Document Detail

Hypertonic-hyperoncotic solutions reduce the release of cardiac troponin I and s-100 after successful cardiopulmonary resuscitation in pigs.
MedLine Citation:
PMID:  12351289     Owner:  NLM     Status:  MEDLINE    
IMPLICATIONS: Infusion of hypertonic-hyperoncotic solutions (HHS) after successful cardiopulmonary resuscitation in pigs significantly reduced the release of cardiac troponin I and cerebral protein S-100, which are sensitive and specific markers of cell damage. Treatment with HHS may provide a new option to improve the outcome of cardiopulmonary resuscitation.
Heiner Krieter; Christof Denz; Christoph Janke; Thomas Bertsch; Thomas Luiz; Klaus Ellinger; Klaus Van Ackern
Related Documents :
8959769 - Out-of-hospital cardiac arrest. evaluation of one year of activity in saint-etienne's e...
1744329 - Preliminary clinical trials of a computer-based cardiac arrest alarm.
19751739 - Preservation of mitochondrial function with cardiopulmonary resuscitation in prolonged ...
21217929 - Current concepts in cardiac ct angiography for patients with acute chest pain.
1659259 - The effect of bicarbonate on resuscitation from cardiac arrest.
7143499 - Role of external cardiac compression in truncal trauma.
9793779 - Basic fibroblast growth factor induces myocardial hypertrophy following acute infarctio...
23508129 - Effect of early statin treatment in patients with cardiogenic shock complicating acute ...
1486589 - Reperfusion arrhythmias after chronic regional denervation of the ischaemic myocardium ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  95     ISSN:  0003-2999     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-09-27     Completed Date:  2002-10-28     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1031-6, table of contents     Citation Subset:  AIM; IM    
Institutes of Anesthesiology and Intensive Care Medicine and Clinical Chemistry, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers
Cardiopulmonary Resuscitation*
Electric Countershock
Epinephrine / therapeutic use
Heart Arrest / physiopathology,  therapy
Hemodynamics / physiology
Hemoglobins / metabolism
Hypertonic Solutions / therapeutic use*
Ischemia / drug therapy
Reperfusion Injury / therapy
S100 Proteins / metabolism*
Troponin I / metabolism*
Vasoconstrictor Agents / therapeutic use
Reg. No./Substance:
0/Biological Markers; 0/Hemoglobins; 0/Hypertonic Solutions; 0/S100 Proteins; 0/Troponin I; 0/Vasoconstrictor Agents; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Substance abuse among physicians: a survey of academic anesthesiology programs.
Next Document:  Endotracheal epinephrine: a call for larger doses.